Alzamend Neuro, Inc. (ALZN) quarterly balance sheet — complete assets, liabilities & equity history
| Total Current Assets | 3.7M | 4.72M | 5.93M | 4.18M | 3.95M | 4.77M | 1.42M | 455.24K | 593.61K | 781.88K | 2.41M | 5.84M |
| Cash & Short-Term Investments | 2.71M | 4.45M | 5.62M | 3.95M | 3.36M | 4.09M | 1.19M | 376.05K | 282.87K | 200.08K | 1.7M | 5.14M |
| Cash Only | 2.71M | 4.45M | 5.62M | 3.95M | 3.36M | 4.09M | 1.19M | 376.05K | 282.87K | 200.08K | 1.7M | 5.14M |
| Short-Term Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accounts Receivable | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Days Sales Outstanding | - | - | - | - | - | - | - | - | - | - | - | - |
| Inventory | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Days Inventory Outstanding | - | - | - | - | - | - | - | - | - | - | - | - |
| Other Current Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Non-Current Assets | 342.55K | 370.24K | 397.92K | 425.61K | 228.29K | 240.98K | 253.66K | 176.35K | 259.03K | 201.72K | 214.4K | 79.84K |
| Property, Plant & Equipment | 342.55K | 370.24K | 397.92K | 425.61K | 228.29K | 240.98K | 253.66K | 176.35K | 189.03K | 201.72K | 214.4K | 79.84K |
| Fixed Asset Turnover | - | - | - | - | - | - | - | 0.43x | - | - | - | - |
| Goodwill | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Long-Term Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 70K | 0 | 0 | 0 |
| Other Non-Current Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Assets | 4.04M | 5.09M | 6.33M | 4.6M | 4.18M | 5.01M | 1.67M | 631.59K | 852.64K | 983.6K | 2.63M | 5.92M |
| Asset Turnover | - | - | - | - | - | - | - | 0.12x | - | - | - | - |
| Asset Growth % | -3.2% | 1.68% | 278.88% | 628.8% | 389.73% | 409.12% | -36.46% | -89.32% | -89.97% | -90.56% | -78.48% | -59.25% |
| Total Current Liabilities | 1.86M | 717.49K | 983.31K | 634.76K | 725.85K | 1.25M | 2.88M | 3.23M | 3.83M | 3.67M | 2.74M | 2.87M |
| Accounts Payable | 1.86M | 717.49K | 983.31K | 634.76K | 725.85K | 1.25M | 2.88M | 2.93M | 3.83M | 3.67K | 2.74M | 2.87M |
| Days Payables Outstanding | 24.49K | 9.46K | 12.96K | 18.26K | 20.89K | 36.1K | 82.93K | 84.17K | 110.1K | 105.49 | 78.87K | 196.81K |
| Short-Term Debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 300.71K | 0 | 0 | 0 | 0 |
| Deferred Revenue (Current) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Current Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Current Ratio | 1.99x | 6.58x | 6.03x | 6.58x | 5.44x | 3.80x | 0.49x | 0.14x | 0.16x | 0.21x | 0.88x | 2.03x |
| Quick Ratio | 1.99x | 6.58x | 6.03x | 6.58x | 5.44x | 3.80x | 0.49x | 0.14x | 0.16x | 0.21x | 0.88x | 2.03x |
| Cash Conversion Cycle | - | - | - | - | - | - | - | - | - | - | - | - |
| Total Non-Current Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1.22M | 0 | 0 | 0 |
| Long-Term Debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Capital Lease Obligations | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred Tax Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1.22M | 0 | 0 | 0 |
| Total Liabilities | 1.86M | 717.49K | 983.31K | 634.76K | 725.85K | 1.25M | 2.88M | 3.23M | 5.05M | 3.67M | 2.74M | 2.87M |
| Total Debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 300.71K | 477.74K | 0 | 0 | 0 |
| Net Debt | -2.71M | -4.45M | -5.62M | -3.95M | -3.36M | -4.09M | -1.19M | -75.33K | 194.87K | -200.08K | -1.7M | -5.14M |
| Debt / Equity | - | - | - | - | - | - | - | - | - | - | - | - |
| Debt / EBITDA | - | - | - | - | - | - | - | - | - | - | - | - |
| Net Debt / EBITDA | - | - | - | - | - | - | - | - | - | - | - | - |
| Interest Coverage | - | -376.79x | -1087.48x | -2237.60x | -513.62x | -388.56x | -80.13x | -580.25x | -1069.13x | -673.16x | -1921.53x | -6368.03x |
| Total Equity | 2.18M | 4.37M | 5.34M | 3.97M | 3.45M | 3.75M | -1.21M | -2.59M | -4.19M | -2.68M | -112.88K | 3.05M |
| Equity Growth % | -36.68% | 16.55% | 540.76% | 252.97% | 182.26% | 239.91% | -973.96% | -185.18% | -171.57% | -130.53% | -101.01% | -77.19% |
| Book Value per Share | 0.57 | 1.29 | 2.54 | 5.58 | 5.63 | 9.56 | -14.21 | -33.93 | -53.51 | -36.78 | -1.55 | 42.48 |
| Total Shareholders' Equity | 2.18M | 4.37M | 5.34M | 3.97M | 3.45M | 3.75M | -1.21M | -2.59M | -4.19M | -2.68M | -112.88K | 3.05M |
| Common Stock | 380 | 380 | 314 | 78 | 580 | 523 | 86 | 69 | 662 | 647 | 9.69K | 9.69K |
| Retained Earnings | -64.44M | -62.24M | -61.24M | -58.54M | -57.4M | -56.41M | -54.99M | -54.02M | -53.17M | -50.51M | -47.6M | -44.07M |
| Treasury Stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accumulated OCI | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -477.74K | -14.88M | -14.88M | -14.88M |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |